Treatment of a cancer using a combination of bendamustine and an anti-CD20 antibody

Details for Australian Patent Application No. 2010204666 (hide)

Owner GlaxoSmithKline LLC

Inventors Thomas, Cherry Teresa; Chan, Geoffrey

Agent Davies Collison Cave

Pub. Number AU-A-2010204666

PCT Pub. Number WO2010/083365

Priority 61/145,210 16.01.09 US

Filing date 15 January 2010

Wipo publication date 22 July 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

21 July 2011 PCT application entered the National Phase

  PCT publication WO2010/083365 Priority application(s): WO2010/083365

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010204680-Beta-amino ester compounds and uses thereof

2010204648-Peptidomimetic macrocycles